Rapport Therapeutics所有資訊

Rapport Therapeutics | SC 13G：超過5%持股股東披露文件-ARCH Venture Fund XII, L.P.(10.2%),ARCH Venture Partners XII, L.P.(10.2%)等

11/14 17:17 (美東)

Rapport Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Cormorant Asset Management, LP(8.04%),Bihua Chen(8.04%)

11/14 15:16 (美東)

Rapport Therapeutics | SC 13G：超過5%持股股東披露文件-Capital International Investors(7.1%)

11/13 12:32 (美東)

Rapport Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

11/12 10:42 (美東)

Rapport Therapeutics | 4：持股變動聲明-董事 Young Wendy B.

11/07 19:03 (美東)

Rapport Therapeutics | 4：持股變動聲明-董事 PEREZ ROBERT J

11/07 19:03 (美東)

Rapport Therapeutics | 4：持股變動聲明-董事 Silva Paul M

11/07 19:03 (美東)

Rapport Therapeutics | 4：持股變動聲明-董事 Sanchez Ramiro

11/07 18:48 (美東)

Rapport Therapeutics | 3：首次持股聲明-董事 PEREZ ROBERT J

11/07 18:48 (美東)

Rapport Therapeutics | 3：首次持股聲明-董事 Silva Paul M

11/07 18:38 (美東)

Rapport Therapeutics | 3：首次持股聲明-董事 Sanchez Ramiro

11/07 18:33 (美東)

Rapport Therapeutics | 3：首次持股聲明-董事 Young Wendy B.

11/07 18:28 (美東)

Rapport Therapeutics | SC 13G：超過5%持股股東披露文件-Johnson & Johnson(6.8%),Johnson & Johnson Innovation-JJDC, Inc.(6.8%)

10/18 17:25 (美東)

Rapport Therapeutics | SC 13G：超過5%持股股東披露文件-FMR LLC(13.624%),Abigail P. Johnson(13.624%)

07/10 10:15 (美東)

Rapport Therapeutics | 4：持股變動聲明-董事 HEALY JAMES

07/03 20:06 (美東)

Rapport Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-THE GOLDMAN SACHS GROUP, INC.(3.5 %),GOLDMAN SACHS & CO. LLC(3.5 %)等

06/24 21:06 (美東)

Rapport Therapeutics | SC 13G：超過5%持股股東披露文件-THE GOLDMAN SACHS GROUP, INC.(7.5 %),GOLDMAN SACHS & CO. LLC(7.5 %)等

06/21 16:56 (美東)

Rapport Therapeutics | SC 13G：超過5%持股股東披露文件-Cormorant Asset Management, LP(8.04%),Bihua Chen(8.04%)等

06/20 16:03 (美東)

Rapport Therapeutics | SC 13D：超過5%持股股東披露文件-Dr. James I. Healy (“Healy”)(5.5%),Sofinnova Venture Partners XI, L.P. (“SVP XI”)(5.3%)等

06/14 16:00 (美東)

Rapport Therapeutics | 4：持股變動聲明-股東 ARCH Venture Partners XII, LLC

06/10 19:49 (美東)